메뉴 건너뛰기




Volumn 121, Issue 3, 2013, Pages 485-488

Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group TARGET Project

(26)  Loh, Mignon L a   Zhang, Jinghui b   Harvey, Richard C c   Roberts, Kathryn b   Payne Turner, Debbie b   Kang, Huining c   Wu, Gang b   Chen, Xiang b   Becksfort, Jared b   Edmonson, Michael d   Buetow, Kenneth H d   Carroll, William L e   Chen, I Ming c   Wood, Brent f   Borowitz, Michael J g   Devidas, Meenakshi h   Gerhard, Daniela S d   Bowman, Paul i   Larsen, Eric j   Winick, Naomi k   more..


Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; JANUS KINASE; PROTEIN TYROSINE KINASE;

EID: 84872457525     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-422691     Document Type: Article
Times cited : (146)

References (20)
  • 1
    • 57849138262 scopus 로고    scopus 로고
    • Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group study
    • Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia. 2008; 22(12): 2142-2150.
    • (2008) Leukemia , vol.22 , Issue.12 , pp. 2142-2150
    • Nguyen, K.1    Devidas, M.2    Cheng, S.C.3
  • 3
    • 47049093795 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study
    • Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008; 111(12): 5477-5485.
    • (2008) Blood , vol.111 , Issue.12 , pp. 5477-5485
    • Borowitz, M.J.1    Devidas, M.2    Hunger, S.P.3
  • 4
    • 70449711127 scopus 로고    scopus 로고
    • Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A Children's Oncology Group study
    • Schultz KR, Bowman WP, Aledo A, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol. 2009; 27(31): 5175-5181.
    • (2009) J Clin Oncol , vol.27 , Issue.31 , pp. 5175-5181
    • Schultz, K.R.1    Bowman, W.P.2    Aledo, A.3
  • 5
    • 70350680415 scopus 로고    scopus 로고
    • Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
    • Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009; 41(11): 1243-1246.
    • (2009) Nat Genet , vol.41 , Issue.11 , pp. 1243-1246
    • Mullighan, C.G.1    Collins-Underwood, J.R.2    Phillips, L.A.3
  • 7
    • 58749109707 scopus 로고    scopus 로고
    • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia
    • Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009; 360(5): 470-480.
    • (2009) N Engl J Med , vol.360 , Issue.5 , pp. 470-480
    • Mullighan, C.G.1    Su, X.2    Zhang, J.3
  • 8
    • 67249146555 scopus 로고    scopus 로고
    • JAK mutations in high-risk childhood acute lymphoblastic leukemia
    • Mullighan CG, Zhang J, Harvey RC, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2009; 106(23): 9414-9418.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.23 , pp. 9414-9418
    • Mullighan, C.G.1    Zhang, J.2    Harvey, R.C.3
  • 9
    • 78649742010 scopus 로고    scopus 로고
    • Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
    • Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116(23): 4874-4884.
    • (2010) Blood , vol.116 , Issue.23 , pp. 4874-4884
    • Harvey, R.C.1    Mullighan, C.G.2    Wang, X.3
  • 10
    • 77954516863 scopus 로고    scopus 로고
    • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
    • Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010; 115(26): 5312-5321.
    • (2010) Blood , vol.115 , Issue.26 , pp. 5312-5321
    • Harvey, R.C.1    Mullighan, C.G.2    Chen, I.M.3
  • 11
    • 77949879862 scopus 로고    scopus 로고
    • Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
    • Kang H, Chen IM, Wilson CS, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(7): 1394-1405.
    • (2010) Blood , vol.115 , Issue.7 , pp. 1394-1405
    • Kang, H.1    Chen, I.M.2    Wilson, C.S.3
  • 12
    • 80052922387 scopus 로고    scopus 로고
    • Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group
    • Zhang J, Mullighan CG, Harvey RC, et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2011; 118(11): 3080-3087.
    • (2011) Blood , vol.118 , Issue.11 , pp. 3080-3087
    • Zhang, J.1    Mullighan, C.G.2    Harvey, R.C.3
  • 13
    • 54349086521 scopus 로고    scopus 로고
    • Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
    • Bercovich D, Ganmore I, Scott LM, et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet. 2008; 372(9648): 1484-1492.
    • (2008) Lancet , vol.372 , Issue.9648 , pp. 1484-1492
    • Bercovich, D.1    Ganmore, I.2    Scott, L.M.3
  • 14
    • 77649214639 scopus 로고    scopus 로고
    • Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: A report from the International BFM Study Group
    • Hertzberg L, Vendramini E, Ganmore I, et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010; 115(5): 1006-1017.
    • (2010) Blood , vol.115 , Issue.5 , pp. 1006-1017
    • Hertzberg, L.1    Vendramini, E.2    Ganmore, I.3
  • 15
    • 70449520449 scopus 로고    scopus 로고
    • Myeloproliferative neoplasms: Contemporary diagnosis using histology and genetics
    • Tefferi A, Skoda R, Vardiman JW. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009; 6(11): 627-637.
    • (2009) Nat Rev Clin Oncol , vol.6 , Issue.11 , pp. 627-637
    • Tefferi, A.1    Skoda, R.2    Vardiman, J.W.3
  • 16
    • 58749097408 scopus 로고    scopus 로고
    • Asubtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: A genomewide classification study
    • Den Boer ML, van Slegtenhorst M, De Menezes RX, et al.Asubtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genomewide classification study. Lancet Oncol. 2009; 10(2): 125-134.
    • (2009) Lancet Oncol , vol.10 , Issue.2 , pp. 125-134
    • Den Boer, M.L.1    Van Slegtenhorst, M.2    De Menezes, R.X.3
  • 17
    • 79961191931 scopus 로고    scopus 로고
    • Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906
    • Bowman WP, Larsen EL, Devidas M, et al. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer. 2011; 57(4): 569-577.
    • (2011) Pediatr Blood Cancer , vol.57 , Issue.4 , pp. 569-577
    • Bowman, W.P.1    Larsen, E.L.2    Devidas, M.3
  • 19
    • 84865118132 scopus 로고    scopus 로고
    • Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
    • Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012; 22(2): 153-166.
    • (2012) Cancer Cell. , vol.22 , Issue.2 , pp. 153-166
    • Roberts, K.G.1    Morin, R.D.2    Zhang, J.3
  • 20
    • 34548084253 scopus 로고    scopus 로고
    • SNPdetector: A software tool for sensitive and accurate SNP detection
    • Zhang J, Wheeler DA, Yakub I, et al. SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol. 2005; 1(5): e53.
    • (2005) PLoS Comput Biol , vol.1 , Issue.5
    • Zhang, J.1    Wheeler, D.A.2    Yakub, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.